小虎
Lv3
210 积分
2023-01-24 加入
-
11. Preoedipal Development in Girls and Boys
2天前
已完结
-
11. Preoedipal Development in Girls and Boys
2天前
已关闭
-
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study
30天前
已完结
-
Discovery of KIN-3248, An Irreversible, Next Generation FGFR Inhibitor for the Treatment of Advanced Tumors Harboring FGFR2 and/or FGFR3 Gene Alterations
1个月前
已完结
-
The influence of safety warnings on the prescribing of JAK inhibitors
2个月前
已关闭
-
2023 AACR CT016(Pemigatinib FIGHT-207) poster
2个月前
已关闭
-
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
3个月前
已完结
-
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
3个月前
已完结
-
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
3个月前
已完结
-
Molecular classification of hormone receptor-positive HER2-negative breast cancer
3个月前
已完结